Breaking News Instant updates and real-time market news.

CMCSA

Comcast

$39.52

0.09 (0.23%)

, AMG

Affiliated Managers

$180.63

1.98 (1.11%)

09:55
07/31/17
07/31
09:55
07/31/17
09:55

Early notable gainers among liquid option names on July 31st

Notable gainers among liquid option names this morning include Comcast (CMCSA) $40.58 +1.07, Affiliated Managers (AMG) $183.22 +4.82, Iron Mountain (IRM) $36.10 +0.92, Bristol Myers Squibb (BMY) $56.54 +1.27, and Frontier Communications (FTR) $15.94 +0.30.

CMCSA

Comcast

$39.52

0.09 (0.23%)

AMG

Affiliated Managers

$180.63

1.98 (1.11%)

IRM

Iron Mountain

$35.69

0.5 (1.42%)

BMY

Bristol-Myers

$56.24

0.97 (1.76%)

FTR

Frontier Communications

$15.63

-0.12 (-0.76%)

  • 31

    Jul

  • 01

    Aug

  • 11

    Sep

  • 24

    Sep

  • 09

    Nov

  • 05

    Mar

CMCSA Comcast
$39.52

0.09 (0.23%)

07/31/17
JPMS
07/31/17
NO CHANGE
Target $450
JPMS
Overweight
Charter offer would likely have to be at least $500 per share, says JPMorgan
JPMorgan analyst Philip Cusick believes SoftBank (SFTBY) is one of the few companies that could offer a big enough price to take control of Charter Communications (CHTR). While a deal is not very likely, Softbank Chairman Masayoshi Son "is never to be counted out as a buyer," Cusick tells investors in a research note. He believes a Charter acquisition offer would likely have to be in the $500 per share or higher range. Charter shares in premarket trading are up $31.74 to $402 after the Wall Street Journal reported Friday night that SoftBank has interest in merging the company with Sprint. Cusick estimates annual synergies between Sprint (S) and Charter could be around $2B, with minimal cost to integrate versus a Sprint and T-Mobile (TMUS) merger "which would have more eventual cost savings but cost much more to integrate." A Sprint and Charter deal would not have a difficult regulatory review, the analyst believes. Cusick adds that if Charter looked like it was going to sell to Softbank, Comcast (CMCSA) would have to decide if it ever did want to buy Charter and "move more quickly with an even bigger premium."
07/26/17
SBSH
07/26/17
NO CHANGE
SBSH
Comcast should acquire Verizon for four reasons, says Citi
Citi analyst Jason Bazinet says Comcast (CMCSA) should acquire Verizon (VZ) for four reasons. Wireless would allow Comcast to extend Internet connectivity beyond the home, the deal would allow the company to push fiber deeper into neighborhoods, Verizon is apt to be the second biggest beneficiary of wireless consolidation, and Comcast could see upside if the tax code changes, Bazinet tells investors in a research note titled "Stars Are Aligning for Comcast + Verizon." The analyst sees the timing for a deal as right given Comcast's history of "trying to acquire assets that have fallen on difficult times" and the potential for a more amendable regulatory landscape under President Trump. Further, 2017 is the first year where Comcast's market capitalization exceeds Verizon's, the analyst adds. He estimates the pro forma combined company would generate $2.1B of annual synergies. Assuming a 20% premium for Verizon's equity, paid via 75% equity and 25% cash, Bazinet estimates Comcast shares would rise to $41. The stock closed yesterday up 28c to $39.75. Bazinet thinks Dish (DISH) could be the biggest loser should Comcast acquire Verizon, and he double downgraded the shares this morning to Sell from Buy.
07/26/17
SBSH
07/26/17
DOWNGRADE
Target $52
SBSH
Sell
Dish downgraded to Sell from Buy at Citi
Citi analyst Jason Bazinet double downgraded Dish (DISH) to Sell from Buy and cut his price target for the shares to $52 from $94. The analyst believes Comcast (CMCSA) should acquire Verizon (VZ), and says such a deal would put "significant pressure" on Dish's equity since Verizon is viewed as the most likely Dish suitor.
07/13/17
TDSI
07/13/17
INITIATION
Target $51
TDSI
Buy
Comcast initiated with a Buy at TD Securities
TD Securities analyst Vince Valentini initiated Comcast with a Buy and a $51 price target.
AMG Affiliated Managers
$180.63

1.98 (1.11%)

06/05/17
06/05/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Sector Weight from Overweight at Pacific Crest with analyst Andy Hargreaves saying upside from the launch of iPhone 8 is already reflected in the shares. An "extremely strong iPhone 8 cycle" is being priced into the stock while little weight is being given to gross margins, supply issues, or the likelihood for declines beyond the iPhone 8, Hargreaves tells investors in a research note. 2. Perrigo (PRGO) downgraded to Underperform from Sector Perform at RBC Capital with analyst Randall Stanicky saying the growth rate of the company's U.S. consumer business "has structurally re-rated lower" amid pricing headwinds and share losses. 3. Endocyte (ECYT) downgraded to Neutral from Outperform at Wedbush and to Market Perform from Outperform at Cowen. 4. Affiliated Managers (AMG) was downgraded to Neutral from Buy at Citi while Federated Investors (FII) was downgraded to Sell from Neutral. 5. Veeva (VEEV) downgraded to Equal Weight from Overweight at Morgan Stanley with the firm's analyst saying the 60%+ move in shares year-to-date captures much of the near-term upside in the stock. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/05/17
SBSH
06/05/17
DOWNGRADE
Target $180
SBSH
Neutral
Affiliated Managers downgraded to Neutral from Buy at Citi
Citi analyst William Katz downgraded Affiliated Managers to Neutral and lowered his price target for the shares to $180 from $185 after reordering his rankings in the Asset Manager space. The analyst believes "winners must have a combination of Active, Passive, Alternatives, digital delivery and risk management acumen."
05/02/17
FBCO
05/02/17
NO CHANGE
Target $194
FBCO
Outperform
Credit Suisse sees Affiliated Managers as 'undervalued'
Following Q1 results, Credit Suisse analyst Craig Siegenthaler reiterated an Outperform rating on Affiliated Managers' stock as he believes it is undervalued relative to its long-term EPS growth prospects. While the analyst is slightly less positive on the company's growth prospects, he still expects Affiliated Managers' EPS to grow above 10%/year. Siegenthaler also thinks its flows may reaccelerate over the next two quarters as its large PE fund raising effort will begin in Q2 and should continue for the next 12 months. He reiterated an Outperform rating on the stock, and lowered his price target on the shares to $194 from $196.
05/02/17
SBSH
05/02/17
NO CHANGE
Target $185
SBSH
Buy
Affiliated Managers removed from Focus List at Citi
Citi analyst William Katz removed Affiliated Managers Group from his firm's U.S. Focus List citing a lack of short-term catalysts. The analyst lowered his price target for the shares to $185 from $205 following the company's Q1 results and keeps a Buy rating on the name. He still sees value in Affiliated Managers.
IRM Iron Mountain
$35.69

0.5 (1.42%)

02/22/17
DBAB
02/22/17
INITIATION
Target $39
DBAB
Hold
Iron Mountain initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Kevin McVeigh started Iron Mountain with a Hold rating and $39 price target.
10/11/16
PIPR
10/11/16
NO CHANGE
Target $48
PIPR
Overweight
Piper sees 'attractive upside' in Iron Mountain shares
Piper Jaffray analyst George Tong sees "attractive upside" in Iron Mountain with the shares down 18% over the past three months. The analyst is "incrementally more confident" in improving services revenue trends and highlights the "durability" of the company's records storage revenue growth. He remains a buyer of the stock with an Overweight rating and $48 price target.
06/07/17
DBAB
06/07/17
DOWNGRADE
Target $30
DBAB
Sell
Iron Mountain downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst Kevin McVeigh downgraded Iron Mountain to Sell and lowered his price target for the shares to $30 from $41. The favorable interest rate environment has provided a selling opportunity in front of "seasonal summer slack," McVeigh tells investors in a research note. The analyst sees a lack of near-term catalysts and prefers to revisit the shares if rates go lower or if internal growth exceeds expectations.
BMY Bristol-Myers
$56.24

0.97 (1.76%)

06/27/17
06/27/17
NO CHANGE

Large cap pharma could benefit from upcoming executive order, says Wells Fargo
Wells Fargo says that, based on press reports, large cap pharma could benefit from President Trump's upcoming executive order on drug pricing. The firm says the articles indicate that the order will not create major reforms or do anything to lower consumers' costs or solve current pricing issues. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/27/17
GSCO
07/27/17
NO CHANGE
Target $63
GSCO
Buy
Bristol-Myers could test $50 level following MYSTIC failure, says Goldman Sachs at Goldman Sachs
Goldman analyst Jami Rubin said Bristol-Myers (BMY) could test the $50 level following the failure of AstraZeneca's MYSTIC trial as confidence gets hit for Bristol's PD-L1+CTLA4 thesis in 1L NSCLC and for its own registration phase 3 trial, CM-227, with a potential interim readout not expected till later in the year. The analyst does not have any contribution from 1L NSCLC in his estimates and note Bristol's assets and trial are very different from MYSTIC. Rubin would view any sell off on the news as a buying opportunity ahead of CM-227 optionality and or potential M&A. The analyst rates Bristol a Buy with a $63 price target.
07/27/17
LEER
07/27/17
NO CHANGE
LEER
Outperform
AstraZeneca trial failure negative for Bristol-Myers, says Leerink
Leerink analyst Seamus Fernandez notes that AstraZeneca (AZN) announced that the MYSTIC trial failed to show a progression-free survival benefit for Imfinzi + tremelimumab compared to chemotherapy in first-line non-small cell lung cancer patients with PDL1 expression greater than 25%. The read through is an obvious negative readthrough for Bristol-Myers' (BMY) combo of Opdivo + Yervoy in the ongoing CheckMate-227 trial, the analyst says. He points out that while there are several key differences in trial design between MYSTIC and CM-227, they are unlikely to result in meaningfully different outcomes. Fernandez reiterates an Outperform rating on Bristol-Myers' shares.
07/28/17
LEER
07/28/17
NO CHANGE
Target $61
LEER
Outperform
Bristol-Myers price target lowered to $61 after Astra trial setback at Leerink
Leerink analyst Seamus Fernandez said Bristol-Myers (BMY) reported "solid" Q2 results, including encouraging growth for its key franchises, but he sees increased uncertainty following the failure of AstraZeneca's (AZN) MYSTIC trial, which has potential read through to Bristol's CheckMate-227 trial of its I/O combo of Opdivo + Yervoy. Fernandez lowered his price target on Bristol shares to $61 from $66, but "fully acknowledges" the range of differences in the trial designs. He keeps an Outperform rating on Bristol-Myers, citing prospects for monotherapy Opdivo approval in the second-line setting and success in first-line liver cancer.
FTR Frontier Communications
$15.63

-0.12 (-0.76%)

05/03/17
COWN
05/03/17
DOWNGRADE
COWN
Market Perform
Frontier Communications downgraded to Market Perform from Outperform at Cowen
05/03/17
COWN
05/03/17
DOWNGRADE
Target $2
COWN
Market Perform
Frontier Communications downgraded to Market Perform at Cowen
As reported previously, Cowen analyst Gregory Williams downgraded Frontier Communications to Market Perform from Outperform as he believes the dividend cut solves little of the fundamental issues facing the company. Although the cut will provide financial flexibility he finds it difficult to recommend a stock that is set up for what may be downward revisions in free cash flow guidance. Williams lowered his price target to $2 from $4 on Frontier Communications shares.
05/08/17
JPMS
05/08/17
NO CHANGE
JPMS
Overweight
TiVo deal with Frontier a 'major positive,' says JPMorgan
JPMorgan analyst Sterling Auty views TiVo's (TIVO) multi-year product deal and IP licensing portfolio renewal with Frontier Communications (FTR) as a "major positive." The analyst believes TiVo's positive momentum is not reflected in its share price. The stock remains undervalued, Auty tells investors in a research note.
05/03/17
UBSW
05/03/17
DOWNGRADE
Target $1.75
UBSW
Neutral
Frontier Communications downgraded to Neutral from Buy at UBS
UBS analyst Batya Levi downgraded Frontier Communications to Neutral following the company's Q1 results and dividend reduction. The analyst lowered her price target for the shares to $1.75 from $5. Citi this morning upgraded Frontier to Neutral.

TODAY'S FREE FLY STORIES

LOW

Lowe's

$75.82

1.97 (2.67%)

, EV

Eaton Vance

$47.16

0.58 (1.25%)

20:25
08/22/17
08/22
20:25
08/22/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

LOW

Lowe's

$75.82

1.97 (2.67%)

EV

Eaton Vance

$47.16

0.58 (1.25%)

AEO

American Eagle

$11.21

0.59 (5.56%)

EXPR

Express

$5.49

0.14 (2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 23

    Aug

  • 23

    Aug

  • 11

    Sep

  • 12

    Sep

  • 13

    Sep

  • 14

    Sep

  • 15

    Sep

  • 21

    Nov

T

AT&T

$37.98

0.4 (1.06%)

, TWX

Time Warner

$101.80

-0.31 (-0.30%)

19:14
08/22/17
08/22
19:14
08/22/17
19:14
Hot Stocks
Mexico regulators approve AT&T-Time Warner deal »

The Instituto Federal de…

T

AT&T

$37.98

0.4 (1.06%)

TWX

Time Warner

$101.80

-0.31 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

REGI

Renewable Energy

$11.20

0.1 (0.90%)

18:50
08/22/17
08/22
18:50
08/22/17
18:50
Hot Stocks
Renewable Energy CEO: Commerce Dept. move 'victory' for job creation »

The U.S Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

INTC

Intel

$34.65

-0.27 (-0.77%)

18:37
08/22/17
08/22
18:37
08/22/17
18:37
Hot Stocks
Former Intel CFO Stacy Smith to retire at the end of January, 2018 »

In an email, Intel CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 29

    Aug

COL

Rockwell Collins

$124.29

0.6 (0.49%)

18:36
08/22/17
08/22
18:36
08/22/17
18:36
Upgrade
Rockwell Collins rating change at Vertical Research »

Rockwell Collins upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$92.95

1.19 (1.30%)

18:24
08/22/17
08/22
18:24
08/22/17
18:24
Hot Stocks
Salesforce CEO says closed large deal with Veterans Administration »

Says federal government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 05

    Sep

WWR

Westwater Resources

$1.32

-0.14 (-9.59%)

18:16
08/22/17
08/22
18:16
08/22/17
18:16
Hot Stocks
Westwater Resources acquires water rights for Columbus Basin Project in Nevada »

Westwater Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTO

ZTO Express

$14.01

0.11 (0.79%)

18:03
08/22/17
08/22
18:03
08/22/17
18:03
Earnings
Breaking Earnings news story on ZTO Express »

ZTO Express sees Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

ZTO

ZTO Express

$14.01

0.11 (0.79%)

18:02
08/22/17
08/22
18:02
08/22/17
18:02
Earnings
ZTO Express reports Q2 earnings per ADS 15c, consensus 14c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

URI

United Rentals

$112.44

4.04 (3.73%)

, CMI

Cummins

$153.10

1.04 (0.68%)

17:48
08/22/17
08/22
17:48
08/22/17
17:48
Hot Stocks
United Rentals acquires power equipment assets from Cummins »

United Rentals (URI) has…

URI

United Rentals

$112.44

4.04 (3.73%)

CMI

Cummins

$153.10

1.04 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

MXIM

Maxim Integrated

$44.39

0.68 (1.56%)

, LZB

La-Z-Boy

$31.25

0.1 (0.32%)

17:40
08/22/17
08/22
17:40
08/22/17
17:40
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Maxim Integrated…

MXIM

Maxim Integrated

$44.39

0.68 (1.56%)

LZB

La-Z-Boy

$31.25

0.1 (0.32%)

CREE

Cree

$23.03

0.46 (2.04%)

VNET

21Vianet

$4.58

0.03 (0.66%)

CRM

Salesforce

$92.95

1.19 (1.30%)

RTNB

root9B Technologies

$2.98

1.72 (136.51%)

RARE

Ultragenyx

$58.85

1.94 (3.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 23

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

  • 16

    Nov

CRM

Salesforce

$92.95

1.19 (1.30%)

17:40
08/22/17
08/22
17:40
08/22/17
17:40
Hot Stocks
Salesforce says sees FY18 margin up 125-150 bps »

Sees "slight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 05

    Sep

MXIM

Maxim Integrated

$44.39

0.68 (1.56%)

17:34
08/22/17
08/22
17:34
08/22/17
17:34
Hot Stocks
Maxim Integrated names Sumeet Gagneja principal accounting officer »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

CTIC

CTI BioPharma

$3.30

0.01 (0.30%)

17:33
08/22/17
08/22
17:33
08/22/17
17:33
Hot Stocks
CTI BioPharma: Chief Business Officer Matthew Plunkett resigns »

Effective August 22,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNM

Unum Group

$47.84

0.51 (1.08%)

17:32
08/22/17
08/22
17:32
08/22/17
17:32
Syndicate
Breaking Syndicate news story on Unum Group »

Unum Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

FTK

Flotek

$5.50

-0.1 (-1.79%)

17:29
08/22/17
08/22
17:29
08/22/17
17:29
Hot Stocks
Flotek announces conclusion of SEC inquiry »

Flotek Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 16

    May

CRM

Salesforce

$92.95

1.19 (1.30%)

17:24
08/22/17
08/22
17:24
08/22/17
17:24
Hot Stocks
Salesforce says 'had best quarter ever' »

Says can reach $20B in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 05

    Sep

THO

Thor Industries

$103.90

0.45 (0.43%)

17:17
08/22/17
08/22
17:17
08/22/17
17:17
Hot Stocks
Jayco announces expansion of Middlebury campus, will add 300 jobs »

Jayco, a subsidiary of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$924.69

18.03 (1.99%)

, GOOGL

Alphabet Class A

$940.40

19.53 (2.12%)

17:14
08/22/17
08/22
17:14
08/22/17
17:14
Hot Stocks
Google introduces Chrome Enterprise »

Google introduced Chrome…

GOOG

Alphabet

$924.69

18.03 (1.99%)

GOOGL

Alphabet Class A

$940.40

19.53 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

VNET

21Vianet

$4.58

0.03 (0.66%)

17:11
08/22/17
08/22
17:11
08/22/17
17:11
Earnings
21Vianet reports Q2 EPS (12c), one estimate (11c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

RTNB

root9B Technologies

$2.98

1.72 (136.51%)

17:05
08/22/17
08/22
17:05
08/22/17
17:05
Hot Stocks
root9B Technologies announces incremental funding, status of foreclosure »

root9B Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPT

Gramercy Property Trust

$29.13

-0.03 (-0.10%)

17:03
08/22/17
08/22
17:03
08/22/17
17:03
Hot Stocks
Gramercy Property Trust launches new JV over Class A distribution centers »

Gramercy Property Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPT

Gramercy Property Trust

$29.13

-0.03 (-0.10%)

17:01
08/22/17
08/22
17:01
08/22/17
17:01
Hot Stocks
Gramercy Property Trust to acquire $479M core logistics portfolio »

Gramercy Property Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIFI

Boingo Wireless

$19.57

0.32 (1.66%)

16:55
08/22/17
08/22
16:55
08/22/17
16:55
Hot Stocks
Boingo Wireless director Michael Finley sells 7,500 shares »

Boingo Wireless director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

RTNB

root9B Technologies

$2.98

1.72 (136.51%)

16:55
08/22/17
08/22
16:55
08/22/17
16:55
Hot Stocks
Breaking Hot Stocks news story on root9B Technologies »

root9B Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.